{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:24:18Z","timestamp":1773300258669,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:00:00Z","timestamp":1629849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:00:00Z","timestamp":1629849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic hepatitis B virus (HBV) infection is a major public health threat for migrant populations in Spain and efforts to scale up testing are needed to reach the WHO elimination targets. The Hepatitis B Virus Community Screening and Vaccination in Africans (HBV-COMSAVA) study aims to use point-of-care testing and simplified diagnostic tools to identify, link to care, or vaccinate African migrants in Barcelona during the COVID-19 pandemic. From 21\/11\/20 to 03\/07\/2021, 314 study participants were offered HBV screening in a community clinic. Rapid tests\u00a0for HBsAg screening were used and blood samples were collected with plasma separation cards. Patients received results and were offered: linkage to specialist care; post-test counselling; or HBV vaccination in situ<jats:italic>.<\/jats:italic> Sociodemographic and clinical history were collected and descriptive statistics were utilized. 274 patients were included and 210 (76.6%) returned to receive results. The HBsAg prevalence was 9.9% and 33.2% of people had evidence of past resolved infection. Overall,\u00a0133 required vaccination, followed by\u00a0post-test counselling (n\u2009=\u2009114), and linkage to a specialist (n\u2009=\u200927). Despite the COVID-19 pandemic, by employing a community-based model of care utilizing novel simplified diagnostic tools, HBV-COMSAVA demonstrated that it was possible to diagnose, link to care, and vaccinate African migrants in community-based settings.<\/jats:p>","DOI":"10.1038\/s41598-021-96350-3","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T10:46:44Z","timestamp":1629888404000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A novel model of care for simplified testing of HBV in African communities during the COVID-19 pandemic in Spain"],"prefix":"10.1038","volume":"11","author":[{"given":"Camila A.","family":"Picchio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel K.","family":"Nomah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia G.","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariadna","family":"Rando-Segura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Buti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Rodr\u00edguez-Tajes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabela","family":"Lens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Rodr\u00edguez-Fr\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey V.","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,25]]},"reference":[{"key":"96350_CR1","unstructured":"World Health Organization. Hepatitis B in the WHO European Region. Fact sheet. July 2017."},{"key":"96350_CR2","unstructured":"World Health Organization. Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. WHO Library Cataloguing-in-Publication Data. 2015."},{"key":"96350_CR3","volume-title":"Global Hepatitis Report 2017","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Global Hepatitis Report 2017 (World Health Organization, 2017)."},{"key":"96350_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S2468-1253(18)30270-X","volume":"4","author":"SG Cooke","year":"2019","unstructured":"Cooke, S. G. et al. Accelerating the elimination of viral hepatitis: A Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol. Hepatol. 4, 135\u2013184 (2019).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"96350_CR5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jhep.2014.10.008","volume":"62","author":"M Lemoine","year":"2015","unstructured":"Lemoine, M., Eholi\u00e9, S. & Lacombe, K. Reducing the neglected burden of viral hepatitis in Africa: Strategies for a global approach. J. Hepatol. 62, 469\u2013476 (2015).","journal-title":"J. Hepatol."},{"key":"96350_CR6","doi-asserted-by":"publisher","first-page":"811","DOI":"10.4321\/S1135-57272014000600012","volume":"88","author":"ES Calder\u00f3n","year":"2014","unstructured":"Calder\u00f3n, E. S. et al. Hepatitis cr\u00f3nicas virales B y C en poblaci\u00f3n inmigrante en Espa\u00f1a. Rev. Esp. Salud Publ. 88, 811\u2013818 (2014).","journal-title":"Rev. Esp. Salud Publ."},{"issue":"6","key":"96350_CR7","doi-asserted-by":"publisher","first-page":"e0234348","DOI":"10.1371\/journal.pone.0234348","volume":"15","author":"J Abesig","year":"2020","unstructured":"Abesig, J., Chen, Y., Wang, H., Sompo, F. M. & Wu, I. X. Y. Prevalence of viral hepatitis B in Ghana between 2015 and 2019: A systematic review and meta-analysis. PLoS ONE 15(6), e0234348 (2020).","journal-title":"PLoS ONE"},{"key":"96350_CR8","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","volume":"30","author":"JJ Ott","year":"2012","unstructured":"Ott, J. J. et al. Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30, 2212\u20132219 (2012).","journal-title":"Vaccine"},{"key":"96350_CR9","doi-asserted-by":"publisher","first-page":"e1024","DOI":"10.1016\/j.ijid.2010.06.013","volume":"14","author":"ER Barth","year":"2010","unstructured":"Barth, E. R. et al. Hepatitis B\/C and HIV in sub-Saharan Africa: An association between highly prevalent infectious diseases. A systematic review and meta-analysis. Int. J. Infect. Dis. 14, e1024\u2013e1031 (2010).","journal-title":"Int. J. Infect. Dis."},{"key":"96350_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.11604\/pamj.2019.33.96.18042","volume":"33","author":"GK Ansa","year":"2019","unstructured":"Ansa, G. K. et al. Hepatitis B vaccine uptake among healthcare workers in a referral hospital, Accra. Pan Afr. Med. J. 33, 96 (2019).","journal-title":"Pan Afr. Med. J."},{"issue":"8","key":"96350_CR11","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41575-019-0177-z","volume":"16","author":"JV Lazarus","year":"2019","unstructured":"Lazarus, J. V. et al. Too many people with viral hepatitis are diagnosed late\u2014With dire consequences. Nat. Rev. Gastroenterol. Hepatol. 16(8), 451\u2013452 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"96350_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14984","author":"S Rodr\u00edguez-Tajes","year":"2020","unstructured":"Rodr\u00edguez-Tajes, S. et al. Significant decrease in the prevalence of hepatitis C infection after the introduction of direct acting antivirals. J. Gastroenterol. Hepatol. https:\/\/doi.org\/10.1111\/jgh.14984 (2020).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"96350_CR13","volume-title":"Public Health Guidance on Screening and Vaccination for Infectious Diseases in Newly Arrived Migrants Within the EU\/EEA","author":"European Centre for Disease Prevention and Control","year":"2018","unstructured":"European Centre for Disease Prevention and Control. Public Health Guidance on Screening and Vaccination for Infectious Diseases in Newly Arrived Migrants Within the EU\/EEA (ECDC, 2018)."},{"key":"96350_CR14","first-page":"280","volume":"99","author":"JU Kim","year":"2021","unstructured":"Kim, J. U., Ingiliz, P., Shimakawa, Y. & Lemoine, M. Improving care for migrants is key for viral hepatitis elimination in Europe. Bull. WHO 99, 280\u2013286 (2021).","journal-title":"Bull. WHO"},{"key":"96350_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12916-017-0856-y","volume":"15","author":"S Mauss","year":"2017","unstructured":"Mauss, S. et al. Late presentation of chronic viral hepatitis for medical care: A consensus definition. BMC Med. 15, 92 (2017).","journal-title":"BMC Med."},{"key":"96350_CR16","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.3390\/v2081504","volume":"2","author":"B Birke","year":"2010","unstructured":"Birke, B. Hepatitis B and C viruses and hepatocellular carcinoma. Viruses 2, 1504\u20131509 (2010).","journal-title":"Viruses"},{"key":"96350_CR17","doi-asserted-by":"publisher","first-page":"101564","DOI":"10.1016\/j.clinre.2020.11.001","volume":"45","author":"JV Lazarus","year":"2021","unstructured":"Lazarus, J. V. et al. Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy. Clin. Res. Hepatol. Gastroenterol. 45, 101564 (2021).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"96350_CR18","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.jhep.2013.01.004","volume":"58","author":"PV Perumalswami","year":"2013","unstructured":"Perumalswami, P. V. et al. Hepatitis outreach network: A practical strategy for hepatitis screening with linkage to care in foreign-born communities. J. Hepatol. 58, 890\u2013897 (2013).","journal-title":"J. Hepatol."},{"issue":"S4","key":"96350_CR19","doi-asserted-by":"publisher","first-page":"S289","DOI":"10.1093\/cid\/ciw090","volume":"62","author":"H Shankar","year":"2016","unstructured":"Shankar, H. et al. A novel collaborative community-based hepatitis B screening and linkage to care program for African immigrants. Clin. Infect. Dis. 62(S4), S289\u2013S297 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"96350_CR20","doi-asserted-by":"publisher","first-page":"114039","DOI":"10.1016\/j.jviromet.2020.114039","volume":"289","author":"J Mart\u00ednez-Campreci\u00f3s","year":"2021","unstructured":"Mart\u00ednez-Campreci\u00f3s, J. et al. Reflex viral load testing in dried blood spots generated by plasma separation card allows the screening and diagnosis of chronic viral hepatitis. J. Virol. Met. 289, 114039 (2021).","journal-title":"J. Virol. Met."},{"key":"96350_CR21","volume-title":"Stata Statistical Software: Release 16","author":"StataCorp","year":"2019","unstructured":"StataCorp. Stata Statistical Software: Release 16 (StataCorp LLC, 2019)."},{"issue":"9","key":"96350_CR22","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S2468-1253(20)30238-7","volume":"5","author":"C Wingrove","year":"2020","unstructured":"Wingrove, C., Ferrier, L., James, C. & Wang, S. The impact of COVID-19 on hepatitis elimination. Lancet Gastroenterol. Hepatol. 5(9), 792\u2013794 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"1","key":"96350_CR23","doi-asserted-by":"publisher","first-page":"e004275","DOI":"10.1136\/bmjgh-2020-004275","volume":"6","author":"CM Pley","year":"2021","unstructured":"Pley, C. M., McNaughton, A. L., Matthews, P. C. & Louren\u00e7o, J. The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection. BMJ Glob. Health 6(1), e004275 (2021).","journal-title":"BMJ Glob. Health"},{"issue":"47","key":"96350_CR24","doi-asserted-by":"publisher","first-page":"2001943","DOI":"10.2807\/1560-7917.ES.2020.25.47.2001943","volume":"25","author":"D Sim\u00f5es","year":"2020","unstructured":"Sim\u00f5es, D., Stengaard, A. R., Combs, L. & Raben, D. The EuroTEST COVID-19 impact assessment consortium of partners. Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020. Euro Surveill. 25(47), 2001943 (2020).","journal-title":"Euro Surveill."},{"issue":"1","key":"96350_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4269\/ajtmh.17-0604","volume":"98","author":"J Salas-Coronas","year":"2018","unstructured":"Salas-Coronas, J. et al. Newly arrived African migrants to Spain: Epidemiology and burden of disease. Am. J. Trop. Med. Hyg. 98(1), 319\u2013325 (2018).","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"4","key":"96350_CR26","first-page":"43","volume":"27","author":"V Hernando","year":"2019","unstructured":"Hernando, V., Ruiz-Alguero, M. & D\u00edaz, A. An\u00e1lisis de la evoluci\u00f3n de la hepatitis B aguda en Espa\u00f1a, 2008\u20132018. Bolet\u00edn Epidemi\u00f3logo Semanal 27(4), 43\u201349 (2019).","journal-title":"Bolet\u00edn Epidemi\u00f3logo Semanal"},{"issue":"14","key":"96350_CR27","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1017\/S0950268817001947","volume":"145","author":"SHI Hofstraat","year":"2017","unstructured":"Hofstraat, S. H. I. et al. Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU\/EEA: A systematic review. Epidemiol. Infect. 145(14), 2873\u20132885 (2017).","journal-title":"Epidemiol. Infect."},{"issue":"12","key":"96350_CR28","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1111\/jvh.13182","volume":"26","author":"LMK Mason","year":"2019","unstructured":"Mason, L. M. K. et al. Hepatitis B and C testing strategies in healthcare and community settings in the EU\/EEA: A systematic review. J. Viral Hepatitis 26(12), 1431\u20131453 (2019).","journal-title":"J. Viral Hepatitis"},{"issue":"6","key":"96350_CR29","doi-asserted-by":"publisher","first-page":"715","DOI":"10.4321\/S1135-57272014000600005","volume":"88","author":"A Llop-Giron\u00e9s","year":"2014","unstructured":"Llop-Giron\u00e9s, A. et al. Immigrants\u2019 access to health care in Spain: A review. Rev. Esp. Salud Publ. 88(6), 715\u2013734 (2014).","journal-title":"Rev. Esp. Salud Publ."},{"key":"96350_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40985-016-0042-3","volume":"37","author":"A Sarr\u00eda-Santamera","year":"2016","unstructured":"Sarr\u00eda-Santamera, A. et al. A systematic review of the use of Health services by immigrants and native populations. Public Health Rev. 37, 28 (2016).","journal-title":"Public Health Rev."},{"key":"96350_CR31","unstructured":"World Health Organization. Guidelines on Hepatitis B and C Testing. Policy brief. November 2016. WHO\/HIV\/2016.23."},{"key":"96350_CR32","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12916-016-0709-0","volume":"14","author":"C Agyemang","year":"2016","unstructured":"Agyemang, C. et al. Obesity and type 2 diabetes in sub-Saharan Africans\u2014Is the burden in today\u2019s Africa similar to African migrants in Europe? The RODAM study. BMC Med. 14, 166 (2016).","journal-title":"BMC Med."},{"issue":"12","key":"96350_CR33","first-page":"1","volume":"1","author":"JV Lazarus","year":"2021","unstructured":"Lazarus, J. V. et al. Vaccinate fast but leave no one behind: A call to action for COVID-19 vaccination in Spain. Commun. Med. 1(12), 1\u20134 (2021).","journal-title":"Commun. Med."},{"issue":"9","key":"96350_CR34","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.3390\/ijerph15091898","volume":"15","author":"DT Myran","year":"2018","unstructured":"Myran, D. T. et al. The effectiveness and cost-effectiveness of screening for and vaccination against hepatitis B virus among migrants in the EU\/EEA: A systematic review. Int. J. Environ. Res. Public Health 15(9), 1898 (2018).","journal-title":"Int. J. Environ. Res. Public Health"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96350-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96350-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96350-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T13:01:10Z","timestamp":1670072470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96350-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,25]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["96350"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-96350-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,25]]},"assertion":[{"value":"13 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CAP, DKN, SGA, ARS, EF and FRF have nothing to declare. MB reports advisory fees from Janssen and Gilead Sciences and grants from Gilead Sciences, outside the submitted work. SR reports speaker fees from Gilead Sciences and Abbvie, outside the submitted work. SL reports speaker\/advisory fees from Gilead Sciences and Abbvie and grants from Gilead Sciences, outside the submitted work. JVL reports grants, personal fees and other from AbbVie and Gilead Sciences, personal fees from CEPHEID, GSK, Intercept and Janssen, and grants and personal fees from MSD, outside the submitted work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17063"}}